miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells
© Sharma et al.; licensee BioMed Central. 2015
Received: 18 August 2014
Accepted: 15 January 2015
Published: 18 February 2015
Japanese encephalitis virus (JEV) is the causative agent of Japanese encephalitis which is more prevalent in South and Southeast Asia. JEV is a neurotropic virus which infiltrates into the brain through vascular endothelial cells. JEV infects neurons and microglial cells which causes neuronal damage and inflammation. However, JEV also evades the cellular immune response to survive in host cells. Viruses are known to modulate the expression of microRNAs, which in turn modulate cellular immune response by targeting expression of antiviral genes. The aim of this study is to understand the anti-inflammatory role of miR-146a during JEV infection, which facilitates immune evasion.
Human brain microglial cells (CHME3) were infected by JEV: JaOArS982 and P20778 strain, and expression of miR-146a were analyzed. Overexpression and knockdown studies of miR-146a were done to see the effect on NF-κB pathway and antiviral Jak-STAT pathway. Regulatory role of miR-146a on expression of interferon-stimulated genes was determined by real-time PCR and luciferase assays.
JEV infection elevated the expression of miR-146a in JaOArS982 strain which caused downregulation of TRAF6, IRAK1, IRAK2, and STAT1 genes. Exogenous overexpression of miR-146a led to suppression of NF-κB activation and abrogation of Jak-STAT pathway upon JEV infection which led to downregulation of interferon-stimulated genes (IFIT-1 and IFIT-2) and facilitated viral replication. JEV infection initially upregulated cytokine production and activated STAT1 activity but STAT1 levels reduced at later time point, which led to the downregulation of interferon-stimulated genes.
Upregulation of miR-146a by JEV JaOArS982 strain leads to suppression of NF-κB activity and disruption of antiviral Jak-STAT signaling which helps the virus to evade the cellular immune response. This effect of JEV infection on miR-146a expression was found to be strain specific.
KeywordsJE miR-146a Neuropathogenesis STAT1 NF-κB activity ISG Viral immune evasion
Japanese encephalitis virus (JEV) is a mosquito-borne neurotropic virus which belongs to the family flaviviridae. JEV is mostly prevalent in South and Southeast Asia. JEV leads to death of 25% of infected patients whereas 50% of survivors suffer from neuronal damage, loss of memory, and cognitive dysfunction . JEV causes encephalitis and death in patients. A comparative study between the different parts of the brain depicted that JEV has more affinity to the midbrain and thalamus . JEV maintains a zoonotic life cycle where pigs are major reservoir hosts and mosquitoes act as vectors . JEV infects macrophages and PBMCs  and infected macrophages help the virus to cross blood brain barrier . However JEV also persists latently in T-lymphocytes  and PBMCs . JEV has been also reported to suppress dendritic cell maturation and causes expansion of Treg cells . Hence, JEV evades the cellular innate response which facilitates its survival in the host. JEV infects microglial cells and causes microglial activation which leads to neuronal damage due to inflammation . Microglial cells are resident macrophages in the brain which harbor JEV. A study on mouse microglial cells demonstrated persistence of JEV in microglial cells and suggested that these cells may serve as reservoirs for virus .
MicroRNAs are the small regulatory RNAs which are 19 to 24 nucleotides in length and are reported to regulate the expression of around 60% of human genes . MicroRNAs (miRNAs) lead to regulation of gene expression by binding to complementary sites present in 3′UTR of target gene via their seed region [12,13]. Viruses modulate the expression of cellular microRNAs  which may help the virus to augment its replication  or in evasion of cellular immune response . Recently, the expression of miR-29b  and miR-155  has been reported to be modulated upon JEV infection. Viruses like DENV, CHIKV and VSV have been reported to overexpress miR-146a which helps the virus to shut down inflammatory responses of cell [19,20,21]. miR-146a is a well-known anti-inflammatory microRNA which targets TNF receptor-associated factor 6 (TRAF6) and IL-1 receptor associated kinase-1 (IRAK1) and IRAK 2 genes . These genes encode for various adaptor proteins involved in NF-κB activation. miR-146a has been also reported to target STAT1 gene which acts as a transcription factor for expression of interferon-stimulated genes . miR-146a is induced by NF-κB activation, where induction of miR-146a targets genes involved in NF-κB activation and forms a regulatory negative feedback loop in monocytes . miR-146a was found to be overexpressed in Tregs and its deficiency led to disruption of immunological tolerance in mice . miR-146a overexpression leads to suppression of cellular inflammatory response and decrease in cytokine secretion [25,26].
In our study, we found that JEV-induced miR-146a upregulation led to the downregulation of TRAF6 and IRAK1 and IRAK2 genes and suppression of NF-κB activation along with decreased expression of pro-inflammatory cytokines. The initial activation of NF-κB by virus resulted in increased expression of miR-146a, which targeted the adapter molecules involved in NF-κB activation through a negative feedback loop. JEV-mediated miR-146a upregulation downregulated the STAT1 expression and abrogated the Jak-STAT pathway, which led to the decreased expression of interferon-stimulated genes (ISGs). This observation suggested the exploitation of cellular miR-146a by JEV to suppress cellular inflammatory responses in order to create favorable cellular environment for their survival.
Materials and methods
Human microglial cell line CHME3 was obtained as a gift from Dr. Anirban Basu (National Brain Research Centre, Manesar, Haryana). CHME3 cells were grown in Complete Dulbecco Modified Eagle Medium (DMEM) (#12100-046, Gibco, Rockville, MD, USA) with 10% heat-inactivated fetal bovine serum (16000–044; Gibco BRL) and 100 U penicillin and 100 μg/ml streptomycin (#10378016; Gibco-BRL). Porcine stable kidney cells (PS cells) for JEV Plaque Assay and C6/36 cells for JEV propagation were also cultured in Complete Dulbecco Modified Eagle Medium.
JEV propagation and infection
JEV strains (JaOArS982 and P20778 Vellore strain) were given as a gift by Dr. Anirban Basu, NBRC which was further propagated in mosquito cell line C6/36 (Aedes albopictus). The 2 × 105 cells were seeded in 75-cm2 flask and infected with JEV at MOI 0.1 in incomplete DMEM (without FBS and antibiotic) medium. The incomplete DMEM media was replaced by complete DMEM media 3 h post infection, and cells were incubated for 8 days in humidified 5% CO2 incubator at 28°C. The supernatant was collected, and the virus was precipitated using PEG virus precipitation kit (#ab102538; Abcam, Cambridge, MA, USA). Virus titer was determined by using plaque assay. For plaque assay, 2 × 105 PS cells were seeded in six-well plates and different dilutions of virus (10−3 to 10−9) were used for infection. Three hours post infection, cells were washed with PBS and agarose overlay medium (2X incomplete DMEM, 5% FBS, 2% low melting agarose, and 1% penicillin-streptomycin) was added on cells and kept at 37°C incubator for 72 h. Later, the cells were fixed by 10% formaldehyde and the overlay was removed. The cells were stained with crystal violet stain, and plaques were counted to determine the virus titer. For infection experiments, 5 × 105 CHME3 cells were seeded in 25 cm2 flask and infected by JEV at MOI 5 in incomplete DMEM. Three hours post infection, the media was replaced by complete DMEM and cells were harvested at 24 h post infection.
Sequence of RNA oligos used
Name of oligos
Anti-miR-146a (miR inhibitor) overexpression
CHME3 cells were transfected with 100 pmol of anti-miR-146a (#AM 10722, Ambion) along with 100 pmol Cy3-labeled scrambled anti-miR (#AM17011; Ambion) as negative control by using Lipofectamine transfection reagent. Cy3-labeled control enables to determine transfection efficiency into cells. Knockdown of miR-146a was confirmed by real-time PCR using Taqman probe. Cells were harvested 48 h post transfection.
RNA isolation and real-time PCR
Qiagen miRNeasy kit (#217004; Qiagen, Venlo, Netherlands) was used for miRNA isolation from harvested cells. Complementary DNA (cDNA) synthesis was done by using multiscribe TaqMan reverse transcriptase (#4366596; Applied Biosystems, Waltham, MA, USA) with miR-146a specific primers. Real-time analysis of miR-146a level was done by real-time PCR (ABI VII A7 RT-PCR) by using miR-146a-specific TaqMan probe and universal PCR master mix (#4324018; Applied Biosystems). The expression of miR-146a was normalized by endogenous control RNU24 expression.
List of primers used for real-time PCR
Forward: 5′ ACTCACCTCTTCAGAACGAATTG 3′
Reverse: 5′CCATCTTTGGAAGGTTCAGGTTG 3′
Forward: 5′ CCTCTCTAATCAGCCCTCTG 3′
Reverse: 5′GAGGACCTGGGAGTAGATGAG 3′
Forward: 5′ AGAGCGGGGAAAAAGGTCAT 3′
Reverse: 5′ TTTCACGCTCTTTCTACAGT 3′
Forward: 5′ ATGGGGGAAGGTGAAGGTCG 3′
Reverse: 5′ GGGGTCATTGATGGCAACAATA 3′
Forward: 5′ AGAAGCAGGCAATCACAGAAAA 3′
Reverse: 5′ CTGAAACCGACCATAGTGGAAAT 3′
Forward: 5′ CACATGGGCCGACTCTCAG 3′
Reverse: 5′ CCACACTTTAACCGTGTCCAC 3′
The harvested cell pellet was lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) with 1 μM PMSF and 1X proteCEASE-50 (#427P; G-Biosciences, St. Louis, MO, USA). The lysate was sonicated, and protein was quantified by bicinchoninic acid (BCA) assay. Equal amount of protein was loaded into each well, resolved on 12% SDS-PAGE gel, and transferred on PVDF membrane. Five percent skimmed milk in 1X TBS-Tween 20 was used for blocking the membrane. The membranes were then incubated in primary antibody (1:1,000) overnight followed by three washes with TBST each for 15 min. Later, the membrane was incubated in HRP-conjugated secondary antibody for 1 h and then washed thrice with 1X TBST (15 min each) and developed by using super-signal developing reagent as HRP substrate. Primary antibodies against TRAF6 (#8028; Cell Signaling Technology, Danver, MA, USA), anti-IRAK1 (#4504; Cell Signaling Technology), anti-IRAK2 (#4367; Cell Signaling Technology), anti-phospho-NFKB p65 (#3037; Cell Signaling Technology), anti-NFKB p65 (#4764; Cell Signaling Technology), anti-STAT1 (#9172 Cell Signaling Technology), anti-phospho-STAT1 (#8826 Cell Signaling Technology), anti-JEV NS1 (#ab41651; Abcam) and anti-β-tubulin (#ab6046; Abcam) antibodies were diluted in 5% BSA in TBST buffer. Goat-raised HRP-conjugated anti-rabbit secondary antibody (ab6721-1; Abcam) was used in 1:50,000 dilution.
CHME3 cells were seeded in six-well dishes and were transfected with NF-κB luciferase reporter plasmid (1 μg) along with β-galactosidase (700 ng) vector by using Lipofectamine 2000. For miR-146a overexpression and anti-miR experiments, 100 pmol of scrambled miR and miR-146a and 100 pmol of Cy3-labeled scrambled anti-miR and anti-miR-146a were co-transfected along with plasmids, and luciferase activity was measured 48 h post transfection. For infection, cells were counted 24 h post transfection and infected with JEV (MOI 5). Cells were incubated for 24 h after infection and were lysed to measure luciferase activity. ISRE and IFN-β luciferase assay was also done in similar manner. Luciferase activity was measured 24 h post infection. For measuring the luminescence activity, cells were lysed in 1X lysis buffer provided by Luciferase Assay kit (#E4030; Promega, Madison, WI, USA) and luminescence was measured by adding luciferase assay reagent as per manufacturer’s protocol. Luciferase activity was measured in Perkin Elmer multiplate reader (Enspire 2300 Multimode plate reader). The luciferase activity was normalized by β-galactosidase activity. β-galactosidase activity was measured by using β-Galactosidase kit (#E2000; Promega, Madison, WI, USA) as per manufacturer’s protocol.
ELISA of TNF-α
CHME3 cells were seeded into six-well plate, and 100 pmol of miR-146a was transfected by using Lipofectamine 2000. Scramble sequence was used as control. Twenty four hours post transfection, JEV infection was given, the supernatant was collected after 24 h, and ELISA was performed to determine secreted TNF-α level by using human TNF-α ELISA kit (#-KHC3011, Invitrogen) according to manufacturer’s protocol. For anti-miR experiments, 100 pmol of anti-miR-146a was transfected along with Cy3-labeled negative control prior to JEV infection.
All experiments were done in triplicates, and comparison was made between all data sets by a one-tailed, unpaired Student’s t-test or one-way ANOVA. Data was considered significant when P < 0.05. * denotes P < 0.05, ** denotes P < 0.005, and *** denotes P < 0.001.
miR-146a gets upregulated during JEV infection
miR-146a enhances JEV replication
Overexpression of miR-146a creates anti-inflammatory milieu in the cell; therefore, we were interested to determine its effect on viral replication in cells. We overexpressed 100 pmol of miR-146a and scramble mimic and gave JEV infection (JaOArS982 strain) after 24 h. The viral RNA level at three time points (12, 24, and 48 h) was checked. We found significant increase by ninefold in viral RNA levels at 24 and a very marginal increase at 12 and 48 h post infection when compared to scramble control (Figure 1B). The effect of miR-146a on viral replication was seen to be time point dependent and got neutralized at 48 h after infection. To further ensure that miR-146a enhances replication of JaOArS982 strain, we suppressed endogenous miR-146a by transfecting anti-miR-146a and gave JEV infection to cells. We found a decrease in viral copy number at all three time points (12, 24, and 48 h) but a significant dip of 75% was observed at 24 h post infection (Figure 1C). Additionally, the effect of miR-146a was checked on expression of viral proteins. We observed the induced expression of the JEV non-structural protein 1 (NS1) in miR-146a overexpressing CHME3 cells as compared to scramble transfected cells 24 h post infection (Figure 1D). Induced expression of NS1 levels was observed at 48 h post infection, which may be due to accumulation of viral proteins (Figure 1D). We also determined the effect of miR-146a on P20778 Vellore strain and found enhanced levels of viral RNA by RT-PCR in miR-146a overexpressing cells (Additional file 1: Figure S1B). These enhanced levels of P20778 viral RNA was also due to anti-inflammatory environment created by miR-146a overexpression. Hence, miR-146a creates a virus-friendly milieu in cells, which promotes JEV replication.
JEV infection downregulates TRAF6, IRAK1, and IRAK2 genes
miR-146a targets TRAF6, IRAK1, and IRAK2 genes
Anti-miR-146a rescues TRAF6, IRAK1, and IRAK2 genes during JEV infection
miR-146a suppresses NF-κB activation and cytokine production
To unveil the downstream effects of miR-146a overexpression which promoted JEV replication, the effect of miR-146a overexpression on NF-κB activation was analyzed. The NF-κB luciferase activity was found to be diminished by 40% in the presence of miR-146a, compared to scramble control (Figure 4D). JEV infection resulted into the downregulation of the luciferase activity by 50% in presence of miR-146a. To further delineate the suppressive effect of miR-146a, miR-146a activity was silenced by anti-miR-146a, which led to the increased luciferase activity. Elevated luciferase activity was observed in the presence of JEV (24 h post-infection) after anti-miR-146a transfection (Figure 4E). JEV infection also elevated NF-κB activity in the presence of anti-miR-146a, compared to untransfected JEV-infected cells (Figure 4E).
The effect of miR-146a overexpression was checked on cytokine production after JEV infection. JEV is known to trigger cytokine secretion in microglial cells. To see the effect of exogenous expression of miR-146a on JEV-induced cytokine production, the transcript levels of IL-6 were checked. We found reduced messenger RNA (mRNA) levels of IL-6 in miR-146a overexpressing cells, compared to scrambled control (Additional file 2: Figure S2A). The levels of TNF-α was also checked by ELISA of supernatants of JEV-infected miR-146a overexpressing CHME3 cells, and we found reduced TNF-α secretion (Additional file 2: Figure S2C). We also analyzed the IFN-β promoter activity in miR-146a overexpressing CHME3 cells after JEV infection and found 50% decrease in IFN-β promoter activity in the presence of miR-146a (Additional file 2: Figure S2E).
miR-146a targets STAT1 gene
Type I interferon activates STAT1 by its phosphorylation and dimerization. JEV has been reported to increase the STAT1 phosphorylation . We observed upregulation in STAT1 phosphorylation (ser727) 12 h post JEV infection (Figure 5A). However, the level of total STAT1 was not changed in 12 h samples. Later, downregulation in total and phospho-STAT1 levels was noticed at 24 h post JEV infection (Figure 5A). We assume that downregulation in STAT1 levels would be due to miR-146a upregulation, which targets expression of STAT1. To confirm our hypothesis, miR-146a was silenced by using anti-miR-146a and found increased STAT1 levels in the presence of JEV (Figure 5D). So we speculate that miR-146a downregulates STAT1 levels which could hinder interferon signaling pathway.
miR-146a suppresses JEV-induced ISRE promoter activity
To study the time-dependent effect of JEV infection on ISRE activity, the luciferase activity was checked at 12 and 24 h post JEV infection. ISRE activity got increased at early time point of 12 h of infection; but later, it decreased at 24 h post JEV infection (Figure 6C). JEV infection suppressed the ISRE activity after 24 h of JEV infection, which weakens the cellular immune response against the virus.
Downregulation of interferon-stimulated genes by miR-146a
JEV modulates pro-inflammatory cytokines and expression of IFIT-1 and IFIT-2
JEV infection leads to neuroinflammation in JEV-infected patients, which leads to high morbidity and mortality. However, the survivors still show neurological and cognitive impairments . JEV has been reported to evade the innate response of host and establish pathogenesis . Recently, Hayasaka et al. reported that JEV JaOArS982 strain infection formed two different disease severity groups in mice, one of which succumbed mild infection with lower levels of TNF-α and IL-10 . They got different results by using different JEV strains. They reported lower titer of JaOArS982 strain in the brain of infected mice, compared to the higher titer of other infective JEV strains, which elicited lower cytokine secretion in mice brain. This data is in support of our findings as our results are also strain specific, and we got decreased levels of miR-146a, in cells infected by JEV (P20778). This suggests that JEV JaOArS982 strain successfully shuts down the cellular inflammatory response to facilitate its survival. Interferon-induced Jak-STAT pathway activates anti-viral machinery of cells, which modulates cellular inflammatory response . Viruses are known to target STAT1 to escape the IFN-induced anti-viral immune response. Simian  and mumps virus [36,37] abrogate Jak-STAT signaling by targeting STAT1. JEV has also been reported to abrogate the Jak-STAT pathway by blocking STAT1 phosphorylation and neutralizing IFN-α-induced anti-viral response . Viruses modulate the cellular microRNA expression for their benefit . miR-122  has been reported to facilitate HCV replication. Vesicular stomatitis, dengue, and Chikungunya virus upregulate miR-146a to suppress cellular inflammatory response [19,20,21]. Enterovirus has been reported to induce miR-141 expression to suppress host translational machinery . JEV has been reported to upregulate miR-29b to suppress the microglial activation  and miR-155 to suppress JEV-induced inflammatory response . In this study, we deciphered the role of microRNA-146a in modulating innate immune response and JEV pathogenesis in human microglial cells.
We report the JEV-mediated increased expression of miR-146a in CHME3 cells. Our results are contradictory to findings of Pareek et al. who found downregulated miR-146a levels upon JEV infection . This discrepancy may be due to different strains of virus used by Pareek et al. To confirm this strain-specific effect of JEV, we determined miR-146a levels in P20778 strain used by Pareek et al. and found similar results to their findings. This suggested that increased expression of miR-146a is strain specific. JEV infection downregulated the adaptor molecules TRAF6, IRAK1, and IRAK2 involved in NF-κB activation, which are targeted by miR-146a. To describe the specific role of miR-146a in targeting of these adaptor molecules, miR-146a was silenced and we found that anti-miR-146a rescued TRAF6, IRAK1, and IRAK2 from downregulation upon JEV infection. To further unveil the downstream effects on NF-κB activity, NF-κB promoter luciferase assay and Western blot analysis were performed. We found reduced luciferase activity at 24 h post JEV infection and reduced phosphorylation of NF-κB p65 subunit upon JEV infection. To confirm the presence of negative feedback loop, we checked the NF-κB luciferase activity at early time points (6 and 12 h) and found initial upregulation in luciferase activity followed by a decrease in luciferase activity at later hours. Initial NF-κB activation by JEV preludes the miR-146a overexpression, which further led to the downregulation of adaptor proteins involved in NF-κB activation and constitute a negative regulatory loop . Hence, we conclude that JEV-mediated upregulation of miR-146a takes place to downregulate NF-κB activation.
miR-146a overexpression suppressed NF-κB activation as demonstrated by luciferase assay, and inhibition of miR-146a enhanced NF-κB activation upon JEV infection. Recently, Jin Ho Paik et al. also reported similar results upon miR-146a overexpression . Our findings demonstrated that miR-146a creates an anti-inflammatory environment in cells. NF-κB subunits act as transcription factor for expression of pro-inflammatory cytokines. miR-146a overexpression also suppressed JEV-induced cytokine production (IL-6, TNF-α, IFN-β). The replication of JEV is increased upon miR-146a overexpression due to an anti-inflammatory environment created by overexpression of miR-146a. However, this enhanced replication of viral RNA was observed only at 24 h post infection and this effect reduced at later time points. To rule out the possibility that this reduced effect on viral replication could be due to degradation of overexpressed miR-146a at later hours, we checked the levels of miR-146a at later hours by RT-PCR and found that the level of miR-146a was retained in CHME3 cells (data not shown). We also found elevated levels of viral NS1 protein in miR-146a overexpressing cells. This may be due to greater accumulation of viral proteins in miR-146a overexpressing cells. Recently, Bing-Ching Ho et al. also reported that miR-146a supports the survival of Enterovirus in mice and silencing of miR-146a improved the survival of Enterovirus-infected mouse due to restoration of interferon production . This suggested that the cellular anti-viral machinery got compromised in miR-146a overexpressing cells and supported viral replication. However, a recent study by Kundu et al. reported increased levels of SOCS1 and SOCS3 during early time points of infection which promoted JEV replication at early time points, but the viral titer got decreased due to the decrease in levels of SOCS1 and SOCS3 during later time points, which led to the activated cellular immune response . We also found a decrease in viral mRNA levels at later time points. This decrease in viral titer in later time points may help the virus to persist latently in cells. Expression of a truncated form of viral NS1 protein and production of low virus titer in persistently JEV-infected murine neuroblastoma cells as an aftermath of virus-cell interaction  also depict that restriction of viral replication can assist viral persistence. Decrease in viral titer at later time points may be due to the activation of cellular immune machinery which nullified the effect of miR-146a overexpression.
miR-146a targets STAT1 gene which leads to abrogation of Jak-STAT pathway . We also found similar results, where miR-146a overexpression reduced the STAT1 levels and inhibition of miR-146a upregulated the STAT1 levels. We also analyzed the effect of miR-146a overexpression on Jak-STAT pathway. Suppression of ISRE promoter activity and downregulated expression of interferon-stimulated genes (ISGs) were found in miR-146a overexpressing cells upon JEV infection. Interferon-induced protein with tetratricopeptide repeat (IFIT) proteins are well-known interferon-induced anti-viral proteins, having anti-proliferative effects . IFIT-1 has been reported to restrict JEV replication . IFIT-2 has been also reported to restrict VSV replication . miR-146a downregulated the JEV induced expression of IFIT-1 and IFIT-2. Downregulation of IFIT levels perturb the cellular anti-viral machinery, which helps in JEV replication in host cells. Tang et al. has reported downregulation of other ISGs (OAS1, Mx1, LY6E) upon miR-146a overexpression . These findings indicated that miR-146a abrogated the Jak-STAT pathway and downregulated the expression of ISGs, which led to the suppression of innate immune response against the virus and augmented the viral replication in miR-146a overexpressing cells.
We also analyzed the effect of JEV infection on STAT1 activation at different time points. JEV induced the STAT1 activation at early time points but downregulated the STAT1 levels at later time points due to targeting of the STAT1 by miR-146a. Inhibition of miR-146a led to the increased STAT1 levels upon JEV infection. The ISRE promoter activity and expression of IFIT-1 and IFIT-2 also displayed similar trends. We observed initial upregulation of ISRE promoter activity and levels of IFIT1 and IFIT2 upon JEV infection, which supported the activation of cellular innate immune machinery against the virus. At 24-h time point, we found decreased levels of IFIT1 and IFIT2 and reduced ISRE promoter activity which indicated that the virus has successfully suppressed the cellular inflammatory response. We observed the decreased expression of IL-6 and TNF-α at 24 h as compared to 12 h post JEV infection. These findings suggest that JEV-mediated miR-146a upregulation led to the suppression of NF-κB activation and STAT1 degradation, caused the downregulation of ISGs at later time point (24 h). Downregulation of ISGs has been reported to facilitate persistence of virus in cells . This is a strategy embraced by JEV to suppress the cellular inflammatory response in human microglial cells and evade innate immune response. However; this effect is time dependent and other strategies adopted by the cell to combat viral replication could play an important role. The host cell triggers various anti-viral signaling pathways to curtail viral replication. Further studies are required to find out other anti-viral strategies adopted by JEV to evade cellular immune response. This study demonstrated strain-specific effects of JEV, as different JEV strains may lead to the varying downstream effects in host cellular immune responses. Understanding the regulatory role of cellular microRNAs during JEV infection in microglial cells would be helpful in understanding the molecular mechanism of JEV neuropathogenesis.
The authors are thankful to Prof. Adolfo Gracia-Sastre, Department of Medicine and Microbiology, Mount Sinai School of Medicine, New York, NY, USA, for providing NF-κB and IFN-β luciferase vector as a kind gift. Authors are thankful to Ms. Ritu Mishra for her suggestions during experiments and manuscript preparation. Authors are thankful to the director, Centre for Cellular and Molecular Biology (CCMB), Hyderabad, for his support. Nikhil Sharma is a recipient of CSIR-Senior Research Fellowship. Authors highly acknowledge the financial support from the DST grant number (INT/Korea/P-08/2011) of the Department of Science and Technology, and grant on RNAi Science and Technology of the Department of Biotechnology, Govt. of India; New Delhi respectively.
- Unni SK, Ruzek D, Chhatbar C, Mishra R, Johri MK, Singh SK. Japanese encephalitis virus: from genome to infectome. Microbes Infect. 2011;13:312–21.View ArticlePubMedGoogle Scholar
- Srivastava R, Kalita J, Khan MY, Gore MM, Bondre VP, Misra UK. Temporal changes of Japanese encephalitis virus in different brain regions of rat. Indian J Med Res. 2013;138:219–23.PubMed CentralPubMedGoogle Scholar
- van den Hurk AF, Ritchie SA, Mackenzie JS. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol. 2009;54:17–35.View ArticlePubMedGoogle Scholar
- Sapkal GN, Wairagkar NS, Ayachit VM, Bondre VP, Gore MM. Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. Am J Trop Med Hyg. 2007;77:1139–45.PubMedGoogle Scholar
- Thongtan T, Thepparit C, Smith DR. The involvement of microglial cells in Japanese encephalitis infections. Clin Dev Immunol. 2012;2012:890586.View ArticlePubMed CentralPubMedGoogle Scholar
- Mathur A, Kulshreshtha R, Chaturvedi UC. Evidence for latency of Japanese encephalitis virus in T lymphocytes. J Gen Virol. 1989;70(Pt 2):461–5.View ArticlePubMedGoogle Scholar
- Sharma S, Mathur A, Prakash V, Kulshreshtha R, Kumar R, Chaturvedi UC. Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol. 1991;85:85–9.View ArticlePubMed CentralPubMedGoogle Scholar
- Cao S, Li Y, Ye J, Yang X, Chen L, Liu X, et al. Japanese encephalitis virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells. Virol J. 2011;8:39.View ArticlePubMed CentralPubMedGoogle Scholar
- Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, et al. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia. 2007;55:483–96.View ArticlePubMedGoogle Scholar
- Thongtan T, Cheepsunthorn P, Chaiworakul V, Rattanarungsan C, Wikan N, Smith DR. Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir. Microbes Infect. 2010;12:37–45.View ArticlePubMedGoogle Scholar
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.View ArticlePubMed CentralPubMedGoogle Scholar
- Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5.View ArticlePubMedGoogle Scholar
- Singh SK, Pal Bhadra M, Girschick HJ, Bhadra U. MicroRNAs – micro in size but macro in function. FEBS J. 2008;275:4929–44.View ArticlePubMedGoogle Scholar
- Gottwein E, Cullen BR. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe. 2008;3:375–87.View ArticlePubMed CentralPubMedGoogle Scholar
- Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol. 2010;64:123–41.View ArticlePubMed CentralPubMedGoogle Scholar
- Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol. 2013;14:205–10.View ArticlePubMed CentralPubMedGoogle Scholar
- Thounaojam MC, Kaushik DK, Kundu K, Basu A. MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem. 2014;129:143–54.View ArticlePubMedGoogle Scholar
- Thounaojam MC, Kundu K, Kaushik DK, Swaroop S, Mahadevan A, Shankar SK, et al. MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1. J Virol. 2014;88:4798–810.View ArticlePubMed CentralPubMedGoogle Scholar
- Wu S, He L, Li Y, Wang T, Feng L, Jiang L, et al. miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect. 2013;67:329–41.View ArticlePubMedGoogle Scholar
- Hou J, Wang P, Lin L, Liu X, Ma F, An H, et al. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol. 2009;183:2150–8.View ArticlePubMedGoogle Scholar
- Selvamani SP, Mishra R, Singh SK. Chikungunya virus exploits miR-146a to regulate NF-kappaB pathway in human synovial fibroblasts. PLoS One. 2014;9:e103624.View ArticlePubMed CentralPubMedGoogle Scholar
- Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009;60:1065–75.View ArticlePubMedGoogle Scholar
- Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103:12481–6.View ArticlePubMed CentralPubMedGoogle Scholar
- Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010;142:914–29.View ArticlePubMed CentralPubMedGoogle Scholar
- Zeng Z, Gong H, Li Y, Jie K, Ding C, Shao Q, et al. Upregulation of miR-146a contributes to the suppression of inflammatory responses in LPS-induced acute lung injury. Exp Lung Res. 2013;39:275–82.View ArticlePubMedGoogle Scholar
- Iyer A, Zurolo E, Prabowo A, Fluiter K, Spliet WG, van Rijen PC, et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One. 2012;7:e44789.View ArticlePubMed CentralPubMedGoogle Scholar
- Pareek S, Roy S, Kumari B, Jain P, Banerjee A, Vrati S. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation. 2014;11:97.View ArticlePubMed CentralPubMedGoogle Scholar
- Saba R, Gushue S, Huzarewich RL, Manguiat K, Medina S, Robertson C, et al. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One. 2012;7:e30832.View ArticlePubMed CentralPubMedGoogle Scholar
- Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 2010;24:2292–300.View ArticlePubMed CentralPubMedGoogle Scholar
- Kundu K, Dutta K, Nazmi A, Basu A. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts’ innate immune response. Cell Immunol. 2013;285:100–10.View ArticlePubMedGoogle Scholar
- Manocha GD, Mishra R, Sharma N, Kumawat KL, Basu A, Singh SK. Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells. J Neuroinflammation. 2014;11:24.View ArticlePubMed CentralPubMedGoogle Scholar
- Aleyas AG, George JA, Han YW, Rahman MM, Kim SJ, Han SB, et al. Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J Immunol. 2009;183:2462–74.View ArticlePubMedGoogle Scholar
- Hayasaka D, Shirai K, Aoki K, Nagata N, Simantini DS, Kitaura K, et al. TNF-alpha acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection. PLoS One. 2013;8:e71643.View ArticlePubMed CentralPubMedGoogle Scholar
- Jenkins BJ. Transcriptional regulation of pattern recognition receptors by Jak/STAT signaling, and the implications for disease pathogenesis. J Interferon Cytokine Res. 2014;10:750–8.View ArticleGoogle Scholar
- Didcock L, Young DF, Goodbourn S, Randall RE. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol. 1999;73:9928–33.PubMed CentralPubMedGoogle Scholar
- Kubota T, Yokosawa N, Yokota S, Fujii N, Tashiro M, Kato A. Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J Virol. 2005;79:4451–9.View ArticlePubMed CentralPubMedGoogle Scholar
- Kubota T, Yokosawa N, Yokota S, Fujii N. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem Biophys Res Commun. 2001;283:255–9.View ArticlePubMedGoogle Scholar
- Lin RJ, Liao CL, Lin E, Lin YL. Blocking of the alpha interferon-induced Jak-STAT signaling pathway by Japanese encephalitis virus infection. J Virol. 2004;78:9285–94.View ArticlePubMed CentralPubMedGoogle Scholar
- Kambara H, Fukuhara T, Shiokawa M, Ono C, Ohara Y, Kamitani W, et al. Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. J Virol. 2012;86:1382–93.View ArticlePubMed CentralPubMedGoogle Scholar
- Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, Hong QS, et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe. 2011;9:58–69.View ArticlePubMedGoogle Scholar
- Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 2011;3:159–66.View ArticlePubMed CentralPubMedGoogle Scholar
- Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, et al. MicroRNA-146a downregulates NF-κB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res. 2011;17:4761–71.View ArticlePubMedGoogle Scholar
- Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY, Tsai CW, et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 2014;5:3344.PubMedGoogle Scholar
- Chen LK, Liao CL, Lin CG, Lai SC, Liu CI, Ma SH, et al. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology. 1996;217:220–9.View ArticlePubMedGoogle Scholar
- Wang S, Zhang X, Ju Y, Zhao B, Yan X, Hu J, et al. MicroRNA-146a feedback suppresses T cell immune function by targeting STAT1 in patients with chronic hepatitis B. J Immunol. 2013;191:293–301.View ArticlePubMedGoogle Scholar
- Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13:46–57.View ArticlePubMed CentralPubMedGoogle Scholar
- Kimura T, Katoh H, Kayama H, Saiga H, Okuyama M, Okamoto T, et al. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5′ capped 2′-O unmethylated RNA. J Virol. 2013;87:9997–10003.View ArticlePubMed CentralPubMedGoogle Scholar
- Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 2012;8:e1002712.View ArticlePubMed CentralPubMedGoogle Scholar
- Ooi EL, Chan ST, Cho NE, Wilkins C, Woodward J, Li M, et al. Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1. Proc Natl Acad Sci U S A. 2014;111:1909–14.View ArticlePubMed CentralPubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.